Human complete NFAT1 deficiency causes a triad of joint contractures, osteochondromas, and B-cell malignancy.

Audi Setiadi, Stuart E Turvey, Millan S Patel, Anthony Cooper, Sylvia Cheng, Anna Lehman, Florian Kuchenbauer, Anna F Lee, Michael S Kobor, Jill Mwenifumbo, Wyeth W Wasserman, Pascal M Lavoie, Mehul Sharma, Jefferson Terry, Meriam Waqas, Kate L Del Bel, Areesha Salman, Joshua Dalmann, Susan Lin, Christina Michalski, Bhavi P Modi, Ashish A Sharma, Henry Y Lu, Maggie P Fu

Journal: Blood 2022;140(17):1858-1874

PMID: 35789258

Abstract

The discovery of humans with monogenic disorders has a rich history of generating new insights into biology. Here we report the first human identified with complete deficiency of nuclear factor of activated T cells 1 (NFAT1). NFAT1, encoded by NFATC2, mediates calcium-calcineurin signals that drive cell activation, proliferation, and survival. The patient is homozygous for a damaging germline NFATC2 variant (c.2023_2026delTACC; p.Tyr675Thrfs∗18) and presented with joint contractures, osteochondromas, and recurrent B-cell lymphoma. Absence of NFAT1 protein in chondrocytes caused enrichment in prosurvival and inflammatory genes. Systematic single-cell-omic analyses in PBMCs revealed an environment that promotes lymphomagenesis with accumulation of naïve B cells (enriched for oncogenic signatures MYC and JAK1), exhausted CD4+ T cells, impaired T follicular helper cells, and aberrant CD8+ T cells. This work highlights the pleiotropic role of human NFAT1, will empower the diagnosis of additional patients with NFAT1 deficiency, and further defines the detrimental effects associated with long-term use of calcineurin inhibitors.

© 2022 by The American Society of Hematology.

Address: Department of Pediatrics, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.; Experimental Medicine Program, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.; Department of Medical Genetics, BC Children's Hospital Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Genome Science and Technology Program, Faculty of Science, The University of British Columbia, Vancouver, BC, Canada.; Department of Pathology, Emory University, Atlanta, GA.; Department of Pathology and Laboratory Medicine, BC Children's Hospital, The University of British Columbia, Vancouver, BC, Canada.; Centre for Molecular Medicine and Therapeutics, The University of British Columbia, Vancouver, BC, Canada.; Terry Fox Laboratory, BC Cancer Agency, The University of British Columbia, Vancouver, BC, Canada.; Department of Orthopaedics, Faculty of Medicine, The University of British Columbia, Vancouver, BC, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.